drugset
drugset / Trial / NCT03511898

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

NCT03511898 ↗

Phase 1 Completed 12 enrolled ThromboGenics
Non-randomizedSequentialOpen-labelTreatment

Summary

This study is conducted to evaluate the safety of a single intravitreal injection of THR-149.

Timeline

Start
2018-05-18
Primary completion
2019-05-22
Completion
2019-05-22

Drugs

EvaluationDrugModalityDoseRoute
Subject THR-149 Unknown — Intravitreal

Indications

diabetes mellitus diabetic macular edema